Your browser doesn't support javascript.
loading
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.
Cardwell, Chris R; Pottegård, Anton; Vaes, Evelien; Garmo, Hans; Murray, Liam J; Brown, Chris; Vissers, Pauline A J; O'Rorke, Michael; Visvanathan, Kala; Cronin-Fenton, Deirdre; De Schutter, Harlinde; Lambe, Mats; Powe, Des G; van Herk-Sukel, Myrthe P P; Gavin, Anna; Friis, Søren; Sharp, Linda; Bennett, Kathleen.
Afiliação
  • Cardwell CR; Institute of Clinical Sciences Block B, Centre for Public Health, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, UK. c.cardwell@qub.ac.uk.
  • Pottegård A; Department of Public Health, University of South Denmark, Odense, Denmark.
  • Vaes E; Research Department, Belgian Cancer Registry, Brussels, Belgium.
  • Garmo H; Division of Cancer Studies, Cancer Epidemiology Unit, King's College London, London, UK.
  • Murray LJ; Regional Cancer Centre Uppsala-Örebro, Uppsala, Sweden.
  • Brown C; Institute of Clinical Sciences Block B, Centre for Public Health, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, UK.
  • Vissers PA; National Cancer Registry Ireland, Cork, Ireland.
  • O'Rorke M; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  • Visvanathan K; Institute of Clinical Sciences Block B, Centre for Public Health, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, UK.
  • Cronin-Fenton D; Johns Hopkins University Bloomberg School of Public Health and School of Medicine, Baltimore, USA.
  • De Schutter H; Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
  • Lambe M; Research Department, Belgian Cancer Registry, Brussels, Belgium.
  • Powe DG; Regional Cancer Centre Uppsala-Örebro, Uppsala, Sweden.
  • van Herk-Sukel MP; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Gavin A; Department of Cellular Pathology, Queens Medical Centre, NUH, Nottingham, UK.
  • Friis S; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
  • Sharp L; Institute of Clinical Sciences Block B, Centre for Public Health, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, UK.
  • Bennett K; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK.
Breast Cancer Res ; 18(1): 119, 2016 12 01.
Article em En | MEDLINE | ID: mdl-27906047
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_breast_cancer Assunto principal: Propranolol / Neoplasias da Mama / Antagonistas Adrenérgicos beta / Inibidores da Angiogênese Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_breast_cancer Assunto principal: Propranolol / Neoplasias da Mama / Antagonistas Adrenérgicos beta / Inibidores da Angiogênese Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido